Wedbush Forecasts Nuvation Bio’s FY2029 Earnings (NYSE:NUVB)
Nuvation Bio Inc. (NYSE:NUVB – Free Report) – Wedbush issued their FY2029 EPS estimates for Nuvation Bio in a report issued on Wednesday, May 7th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings per share of $3.26 for the year. Wedbush has a “Outperform” rating and a $5.00 price objective on the […]
